Skip to main content

Table 1 Univariate analyses of risk factors associated with DVT following surgeries of tibial plateau fracture

From: Incidence and locations of deep venous thrombosis of the lower extremity following surgeries of tibial plateau fractures: a prospective cohort study

Variables

Number (%) of DVT (n = 46)

Number (%) of non-DVT (n = 941)

P

Gender (male)

30 (65.2)

573 (60.9)

0.557

Age (years)

49.8 ± 13.1

45.0 ± 13.9

0.020

 18–40

9 (19.6)

388 (41.2)

0.003

 ≥ 41

37 (80.4)

553 (58.8)

Living area

< 0.001

 Rural

27(58.7)

577(61.2)

 Urban

19(39.1)

365(38.8)

BMI (kg/m2)

0.934

 18.5–23.9

14 (30.4)

306 (32.5)

 < 18.5

1 (2.2)

18 (1.9)

 24–27.9

20 (43.5)

389 (41.3)

 ≥ 28.0

11 (23.9)

228 (24.3)

Diabetes mellitus

5 (10.9)

126 (13.4)

0.623

Hypertension

7 (15.2)

160 (17.0)

0.752

Cerebrovascular disease

0

12(1.3)

0.441

Chronic heart disease

2 (4.3)

40 (4.3)

0.975

Chronic liver disease

2 (4.3)

45 (4.8)

0.893

History of any surgery

7 (15.2)

109 (11.6)

0.455

Allergy to any medications

5 (10.9)

116 (12.3)

0.768

Current smoking

6 (13.0)

123 (13.1)

0.996

Alcohol consumption

8 (17.4)

83 (8.8)

0.050

Preoperative duration (day)

7.1 ± 7.8

6.8 ± 6.7

0.781

Total hospital stay

29.8 ± 26.8

18.6 ± 22.2

0.001

Mechanism (high-energy)

30(65.2)

608(64.6)

0.933

Open fracture

5(10.9)

44(4.7)

0.059

ASA class

0.085

 I

4 (8.7)

134 (14.2)

 II

31(67.4)

684 (72.7)

 III or above

11 (23.9)

123 (13.1)

Fracture type (Schartzker)

0.397

 I–IV

31 (67.4)

669 (71.1)

 V–VI

15 (32.6)

272 (28.9)

Anesthesia (general)

28(60.9)

369(39.2)

0.003

Open reduction (vs closed)

34 (93.5)

96(91.2)

0.589

Bone grafting (yes)

13(28.3)

186(19.8)

0.161

Surgical duration

182.4 ± 77.0

148.6 ± 82.0

0.012

Perioperative blood transfusion

7 (15.2)

97 (10.3)

0.290

Operation timing

0.942

 Day

45(97.8)

922(98.0)

 Night

1(2.2)

19(2.0)

TP (< 60 g/L)

19 (41.3)

242 (25.7)

0.019

ALB (< 35 g/L)

14 (30.4)

189 (20.1)

0.090

A/G

0.111

 1.2–2.4

38 (82.6)

835 (89.8)

 < 1.2

7(15.2)

66(7.0)

 > 2.4

1(2.2)

30(3.2)

ALT (> 40 U/L)

7(15.2)

173(18.4)

0.587

AST (> 35 U/L)

6(13.0)

128(13.6)

0.914

TBIL (> 21 umol/L)

4(8.7)

78(8.3)

0.922

DBIL (> 6 umol/L)

17(37.0)

257(27.3)

0.154

IBIL (> 14 umol/L)

8(17.4)

142(15.1)

0.671

ALP (> 100)

3(6.5)

38(4.0)

0.410

HCRP (> 8 mg/L)

37(80.4)

627(66.6)

0.051

LDH (> 250 U/L)

16(34.8)

198(21.0)

0.027

HBDH (> 182 U/L)

13(28.3)

153(16.3)

0.034

TC (> 5.2 mmol/L)

3(6.5)

118(12.5)

0.224

TG (> 1.7 mmol/L)

4(8.7)

163(17.3)

0.128

HDL-C (< 1.1 mmol/L)

23(50.0)

365(38.8)

0.128

LDL-C (> 3.37 mmol/L)

6(13.0)

129(13.7)

0.898

VLDL (> 0.78 mmol/L)

4(8.7)

158(16.8)

0.148

Na + (< 135 mmol/L)

23(50.0)

263(27.9)

0.001

K+ (mmol/L)

  

0.001

 3.5–5.5

40(87.0)

874(92.9)

 < 3.5

3(6.5)

60(6.4)

 > 5.5

3(6.5)

7(0.7)

UA (> upper limit)

1(2.2)

77(8.2)

0.140

WBC (> 10 × 109/L)

20(43.5)

290(30.8)

0.071

LYM (< 1.1 × 109/L)

17(37.0)

266(28.3)

0.203

MON (> 0.6 × 109/L)

30(65.2)

562(59.7)

0.458

RBC < lower limit

21(45.7)

367(39.0)

0.367

HGB < lower limit

31(67.4)

495(52.6)

0.049

HCT < lower limit

34(73.9)

571(60.7)

0.072

MCV (fL)

0.830

 82–100

43 (93.5)

875 (93.0)

 < 82

1 (2.2)

34 (3.6)

 > 100

2 (4.3)

32 (3.4)

MCH (pg)

0.585

 27–34

42 (91.3)

861 (91.5)

 < 27

3 (6.5)

39 (4.1)

 > 34

1 (2.2)

41 (4.4)

MCHC (< 316 g/L)

3(6.5)

26(2.8)

0.134

PDW (%)

0.197

 12–18.1

42 (91.3)

829 (88.1)

 < 12

2 (4.3)

96 (10.2)

 > 18.1

2 (4.3)

16 (1.7)

D-dimer (> 0.50 mg/L)

32 (69.6)

528 (56.1)

0.072

D-dimer (> 1.76 mg/L)

22 (47.8)

231 (24.5)

< 0.001

OSM < 260 mOsm/L

10 (21.7)

85 (9.0)

0.004

PLT > 300 × 109/L

15 (32.6)

200 (21.3)

0.068

NEUT > 6.3 × 109/L

27 (58.7)

441 (46.9)

0.117

FBG (> 6.1 mmol/L)

16 (34.8)

318 (33.8)

0.890

RDW (> 16.5%)

5 (5.1)

54 (3.8)

0.506

  1. BMI body mass index; ASA American Society of Anesthesiologists; RBC red blood cell, reference range: females, 3.5–5.0 × 1012/L; males, 4.0–5.5 × 1012/L. HGB hemoglobin, reference range: females, 110–150 g/L; males, 120–160 g/L; FBG fasting blood glucose; HCT hematocrit, 40–50%; WBC white blood cell; NEUT neutrophile; LYM lymphocyte; PLT platelet, 100–300 × 109/L; TP total protein; ALB albumin; RDW red cell distribution width; PDW platelet distribution width; TC total cholesterol; TG triglyceride; LDL-C low-density lipoprotein; HDL-C high-density lipoprotein; VLDL very low-density lipoprotein